|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 |
| (11) | Number of the document | 2173378 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08779855.9 |
| Date of filing the European patent application | 2008-06-27 | |
| (97) | Date of publication of the European application | 2010-04-14 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/008084 |
| Date | 2008-06-27 |
| (87) | Number | WO 2009/002562 |
| Date | 2008-12-31 |
| (30) | Number | Date | Country code |
| 937471 P | 2007-06-27 | US |
| (72) |
PAVLAKIS, George, N., US
VOURNAKIS, John, N., US
FELBER, Barbara, K., US
FINKIELSZTEIN, Sergio, US
|
| (73) |
Admune Therapeutics LLC,
107 Water Street, Danvers, MA 01923,
US
The United States Of America,As Represented By The Secretary, Department Of Health And Human Services, Office Of Technology Transfer National Institute Of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US |
| (54) | COMPLEXES OF IL-15 AND IL-15RALPHA AND USES THEREOF |
| COMPLEXES OF IL-15 AND IL-15RALPHA AND USES THEREOF |